Get started
Author

Gergana Tsvetkova

Observed names: G Tsvetkova, G. Tsvetkova, Сурчева
ORCID: 0000-0003-2613-7489
Observed ORCID: 0000-0003-2613-7489
OpenAlex ID: A5102711532
Characterization of mesenchymal stem cells isolated from the human umbilical cord
2008 · Snejana Kestendjieva, Dobroslav Kyurkchiev, et al. · Cell Biology International · 116
Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis
2020 · Milena Ivanova, Gergana Tsvetkova, et al. · Experimental Hematology · 17
Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F ‐positive myeloproliferative neoplasms
2023 · Milena Ivanova, Gergana Tsvetkova, et al. · HLA · 5
The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms
2023 · Velizar Shivarov, Gergana Tsvetkova, et al. · Human Immunology · 5
Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms
2024 · Velizar Shivarov, Gergana Tsvetkova, et al. · Frontiers in Immunology · 4
PDF
Biclonal myeloma in renal failure
2020 · Milena K. Nikolova-Vlahova, Miroslava Kamburova, et al. · Central European Journal of Immunology · 3
PDF
Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms
2026 · Velizar Shivarov, Gergana Tsvetkova, et al. · Cancers · 2
PDF
Ocular Manifestations In COVID-19: Clinical Case Reports And A Literature (Review)
2021 · A. Oscar, Y. Zdravkov, et al. · Bulgarian Review of Ophthalmology · 2
PDF
Inhibitory HLA‐C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome‐Negative Myeloproliferative Neoplasms
2026 · Velizar Shivarov, Gergana Tsvetkova, et al. · eJHaem · 1
P1001: Modulation of Mutant Calreticulin-driven Oncogenesis in Myeloproliferative Neoplasms by Classical Hla Genes
2023 · Velizar Shivarov, Gergana Tsvetkova, et al. · HemaSphere · 1
Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms
2024 · Velizar Shivarov, Gergana Tsvetkova, et al. · Annals of Hematology
P1064: Circulating Cytokine Levels in Patients With Philadelphia-negative Myeloproliferative Neoplasms – Profile and Clinical Correlations – a Single Center Study
2022 · G. Tsvetkova, S. Mihailova, et al. · HemaSphere
Ophthalmic Status of Newborn Children at Risk – Preliminary Results
2022 · G. Tsvetkova, A. Oscar · Bulgarian Review of Ophthalmology
PDF
Take the Risk or Lose the Chance!
2021 · G. Tsvetkova, Y. Zdravkov, et al. · Trakia Journal of Sciences
PDF
Primary Extranodal Non-hodgkin’s Lymphoma Involving Right Maxilla
2020 · Elitsa Deliverska, Evgenii Hadjiev, et al. · Journal of IMAB - Annual Proceeding (Scientific Papers)
PDF
Pb1770 Rare Variants of Cbfb‐myh11 Transcripts in Acute Myeloid Leukemia: Contribution With 3 Cases
2019 · G. Balatzenko, S. Ivanova, et al. · HemaSphere
Psy222 - Health Related Quality of Life (hrqol) in Multiple Myeloma (mm) Patients in Bulgaria
2018 · S. Georgieva, G. Tsvetkova, et al. · Value in Health
PDF
Predictive factors for the development of post-operative fibrinous exudation
2018 · Y. Zdravkov, E. Yankova, et al. · Bulgarian Review of Ophthalmology
PDF
Pseudothrombocytosis in a Patient with Heterozygous Beta-Thalassaemia
2018 · M. Velizarova, Gergana Tsvetkova, et al. · International Journal of Health Sciences and Research
Analysis Of Health-Related Quality Of Life (HRQOL), And Costs Of Treatment In Chronic Myelogenic Leukemia (CML) In Bulgaria
2017 · S Georgieva, G Tsvetkova, et al. · Value in Health
PDF
A program for assessment of the attitude of patients treated with tyrosine kinase inhibitors to chronic myelogenous leukemia: initial results.
2015 · Вандова, Г. Vandova, et al. · Bulgarian Portal for Open Science
Works count: 21
Citation count: 156
H-index: 4
I10-index: 2
Year
Topic
Type